T cell receptor (TCR) antagonism without a negative signal: Evidence from T cell hybridomas expressing two independent TCRs

Journal of Experimental Medicine

Volumn 189, Issue 2, 1999, Pages 253-263

  Stotz, Sabine H ^a   Bolliger, Luca ^a   Carbone, Francis R ^b   Palmer, Ed ^a  

^a BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^b MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

Author keywords

T cell activation; T cell commitment; T cell receptor antagonist

Indexed keywords

LIGAND; LYMPHOCYTE RECEPTOR; PEPTIDE;

ANIMAL CELL; ARTICLE; COMPETITIVE INHIBITION; HYBRIDOMA; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANTIGENS; BINDING, COMPETITIVE; DOWN-REGULATION; HYBRIDOMAS; INTERLEUKIN-2; KINETICS; LIGANDS; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0033579813     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.2.253     Document Type: Article

References (65)

1. Garcia, K.C., M. Degano, R.L. Stanfield, A. Brunmark, M.R. Jackson, P.A. Peterson, L. Teyton, and I.A. Wilson. 1996. An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science. 274:209-219.
2. Garboczi, D.N., P. Ghosh, U. Utz, Q.R. Fan, W.E. Biddison, and D.C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 384:134-141.
3. Perlmutter, R.M., S.D. Levin, M.W. Appleby, S.J. Anderson, and J. Alberola-Ila. 1993. Regulation of lymphocyte function by protein phosphorylation. Annu. Rev. Immunol. 11:451-499.
4. Chan, A.C., D.M. Desai, and A. Weiss. 1994. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu. Rev. Immunol. 12:555-592.
5. Wange, R.L., and L.E. Samelson. 1996. Complex complexes: signaling at the TCR. Immunity. 5:197-205.
6. Cantrell, D. 1996. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14:259-274.
7. De-Magistris, M.T., J. Alexander, M. Coggeshall, A. Altman, F.C. Gaeta, H.M. Grey, and A. Sette. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell. 68:625-634.
8. Racioppi, L., F. Ronchese, L.A. Matis, and R.N. Germain. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177:1047-1060.
9. Jameson, S.C., F.R. Carbone, and M.J. Bevan. 1993. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 177:1541-1550.
10. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, et al. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature. 369:403-407.
11. Bertoletti, A., A. Sette, F.V. Chisari, A. Penna, M. Levrero, M. De-Carli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature. 369:407-410.
12. Sette, A., J. Alexander, J. Ruppert, K. Snoke, A. Franco, G. Ishioka, and H.M. Grey. 1994. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 12:413-431.
13. Jameson, S.C., and M.J. Bevan. 1995. T cell receptor antagonists and partial agonists. Immunity. 2:1-11.
14. Janeway, C.A., Jr. 1995. Ligands for the T-cell receptor: hard times for avidity models. Immunol. Today. 16:223-225.
15. Kersh, G.J., and P.M. Allen. 1996. Review: essential flexibility in the T-cell recognition of antigen. Nature. 380:495-498.
16. Madrenas, J., and R.N. Germain. 1996. Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation. Semin. Immunol. 8:83-101.
17. Ruppert, J., J. Alexander, K. Snoke, M. Coggeshall, E. Herbert, D. McKenzie, H.M. Grey, and A. Sette. 1993. Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events. Proc. Natl. Acad. Sci. USA. 90:2671-2675.
18. McKeithan, T.W. 1995. Kinetic proofreading in T-cell receptor signal transduction. Proc. Natl. Acad. Sci. USA. 92: 5042-5046.
19. Preckel, T., R. Grimm, S. Martin, and H. Weltzien. 1997. Altered hapten ligands antagonize trinitrophenyl-specific cytotoxic T cells and block internalization of hapten-specific receptors. J. Exp. Med. 185:1803-1813.
20. Sloan-Lancaster, J., B.D. Evavold, and P.M. Allen. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature. 363:156-159.
21. Sloan-Lancaster, J., T.H. Steinberg, and P.M. Allen. 1996. Selective activation of the calcium signaling pathway by altered peptide ligands. J. Exp. Med. 184:1525-1530.
22. 8+ cytotoxic T cells after stimulation with T cell agonists, partial agonists and antagonists. Eur. J. Immunol. 27:3414-3419.
23. Matsui, K., J.J. Boniface, P. Steffner, P.A. Reay, and M.M. Davis. 1994. Kinetics of T-cell receptor binding to peptide/ I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc. Natl. Acad. Sci. USA. 91:12862-12866.
24. Alam, S., P. Travers, J. Wung, W. Nasholds, S. Redpath, S. Jameson, and N. Gascoigne. 1996. T-cell-receptor affinity and thymocyte positive selection. Nature. 381:616-620.
25. Lyons, D., S. Lieberman, J. Hampl, J. Boniface, Y. Chien, L. Berg, and M. Davis. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity. 5:53-61.
26. Sloan-Lancaster, J., A.S. Shaw, J.B. Rothbard, and P.M. Allen. 1994. Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell. 79:913-922.
27. Madrenas, J., R.L. Wange, J.L. Wang, N. Isakov, L.E. Samelson, and R.N. Germain. 1995. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science. 267:515-518.
28. 8+ T cells in response to antagonist ligands. J. Exp. Med. 184:149-157.
29. Rabinowitz, J.D., C. Beeson, D.S. Lyons, M.M. Davis, and H.M. McConnell. 1996. Kinetic discrimination in T-cell activation. Proc. Natl. Acad. Sci. USA. 93:1401-1405.
30. Racioppi, L., G. Matarese, U. D'Oro, M. De Pascale, A.M. Masci, S. Fontana, and S. Zappacosta. 1996. The role of CD4-Lck in T-cell receptor antagonism: evidence for negative signaling. Proc. Natl. Acad. Sci. USA. 93:10360-10365.
31. Yoon, S., U. Dianzani, K. Bottomly, and C.J. Janeway. 1994. Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity. Immunity. 1:563-569.
32. Hogquist, K.A., S.C. Jameson, W.R. Heath, J.L. Howard, M.J. Bevan, and F.R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell. 76:17-27.
33. Jameson, S.C., K.A. Hogquist, and M.J. Bevan. 1994. Specificity and flexibility in thymic selection. Nature. 369:750-752.
34. 8+ T cells. Immunity. 3:79-86.
35. Kelly, J., S. Sterry, S. Cose, S. Turner, J. Fecondo, S. Rodda, P. Fink, and F. Carbone. 1993. Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant. Eur. J. Immunol. 23:3318-3326.
36. Miller, A.D., and G.J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. Biotechniques. 7: 980-990.
37. Morgenstern, J.P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids. Res. 18:3587-3596.
38. Mullen, C.A., M. Kilstrup, and R.M. Blaese. 1992. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc. Natl. Acad. Sci. USA. 89:33-37.
39. Bäckström, B.T., E. Milia, A. Peter, B. Jaureguiberry, C.T. Baldari, and E. Palmer. 1996. A motif within the T cell receptor alpha chain constant region connecting peptide domain controls antigen responsiveness. Immunity. 5:437-447.
40. Turner, S.J., S.C. Cose, and F.R. Carbone. 1996. TCR alpha-chain usage can determine antigen-selected TCR beta-chain repertoire diversity. J. Immunol. 157:4979-4985.
41. Letourneur, F., and B. Malissen. 1989. Derivation of a T cell hybridoma variant deprived of functional T cell receptor alpha and beta chain transcripts reveals a nonfunctional alpha-mRNA of BW5147 origin. Eur. J. Immunol. 19:2269-2274.
42. Wallny, H.J., O. Rotzschke, K. Falk, G. Hammerling, and H.G. Rammensee. 1992. Gene transfer experiments imply instructive role of major histocompatibility complex class I molecules in cellular peptide processing. Eur. J. Immunol. 22: 655-659.
43. Watson, J. 1979. Continuous proliferation of murine antigen-specific helper T lymphocytes in culture. J. Exp. Med. 150:1510-1519.
44. Bill, J., O. Kanagawa, J. Linten, Y. Utsunomiya, and E. Palmer. 1990. Class I and class II MHC gene products differentially affect the fate of V beta 5 bearing thymocytes. J. Mol. Cell. Immunol. 4:269-280.
45. Leo, O., M. Foo, D.H. Sachs, L.E. Samelson, and J.A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA. 84: 1374-1378.
46. Rozdzial, M.M., R.T. Kubo, S.L. Turner, and T.H. Finkel. 1994. Developmental regulation of the TCR zeta-chain. Differential expression and tyrosine phosphorylation of the TCR zeta-chain in resting immature and mature T lymphocytes. J. Immunol. 153:1563-1580.
47. + T cells in mouse strains expressing both H-2k and T cell receptor V alpha a haplotypes: determination with a V alpha 2-specific monoclonal antibody. Eur. J. Immunol. 22:399-404.
48. Necker, A., N. Rebai, M. Matthes, E. Jouvin-Marche, P.A. Cazenave, P. Swarnworawong, E. Palmer, H.R. MacDonald, and B. Malissen. 1991. Monoclonal antibodies raised against engineered soluble mouse T cell receptors and specific for V alpha 8-, V beta 2-or V beta 10-bearing T cells. Eur. J. Immunol. 21:3035-3040.
49. Loken, M.R., and A.M. Stall. 1982. Flow cytometry as an analytical and preparative tool in immunology. J. Immunol. Methods. 50:R85-R112.
50. Jones, B., and C.A. Janeway, Jr. 1981. Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted. Nature. 292:547-549.
51. Bolliger, L., B. Johansson, and E. Palmer. 1997. The short extracellular domain of the T cell receptor zeta chain is involved in assembly and signal transduction. Mol. Immunol. 34: 819-827.
52. Renard, V., P. Romero, E. Vivier, B. Malissen, and I.F. Luescher. 1996. CD8 beta increases CD8 coreceptor function and participation in TCR-ligand binding. J. Exp. Med. 184: 2439-2444.
53. Valitutti, S., S. Muller, M. Cella, E. Padovan, and A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature. 375:148-151.
54. Viola, A., S. Linkert, and A. Lanzavecchia. 1997. A T cell receptor (TCR) antagonist competitively inhibits serial TCR triggering by low-affinity ligands, but does not affect triggering by high-affinity anti-CD3 antibodies. Eur. J. Immunol. 27: 3080-3083.
55. Bachmann, M.F., M. Salzmann, A. Oxenius, and P.S. Ohashi. 1998. Formation of T cell receptor dimers/trimers as a crucial step for T cell activation. Eur. J. Immunol. 28:2571-2579.
56. Jacobs, H. 1997. Pre-TCR/CD3 and TCR/CD3 complexes: decamers with differential signalling properties? Immunol. Today. 18:565-569.
57. Monks, C.R., B.A. Freiberg, H. Kupfer, N. Sciaky, and A. Kupfer. 1998. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature. 395:82-86.
58. La Face, D.M., C. Couture, K. Anderson, G. Shih, J. Alexander, A. Sette, T. Mustelin, A. Altman, and H.M. Grey. 1997. Differential T cell signaling induced by antagonist peptide-MHC complexes and the associated phenotypic responses. J. Immunol. 158:2057-2064.
59. Hemmer, B., I. Stefanova, M. Vergelli, R.N. Germain, and R. Maring. 1998. Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells. J. Immunol. 160:5807-5814.
60. Cantrell, D.A., and K.A. Smith. 1984. The interleukin-2 T-cell system: a new cell growth model. Science. 224:1312-1316.
61. Weiss, A., R. Shields, M. Newton, B. Manger, and J. Imboden. 1987. Ligand-receptor interactions required for commitment to the activation of the interleukin 2 gene. J. Immunol. 138:2169-2176.
62. Crabtree, G.R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science. 243:355-361.
63. Iezzi, G., K. Karjalainen, and A. Lanzavecchia. 1998. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity. 8:89-95.
64. 4+ T cell anergy in vitro. J. Exp. Med. 187:89-96.
65. Smith, J.A., and J.A. Bluestone. 1997. T cell inactivation and cytokine deviation promoted by anti-CD3 mAbs. Curr. Opin. Immunol. 9:648-654.